Kim Smith-Whitley

Insider Reports History

Entity
Individual
Location
C/O Global Blood Therapeutics, Inc., 181 Oyster Point Blvd., South San Francisco, CA
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kim Smith-Whitley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Global Blood Therapeutics, Inc. Officer Title: EVP, Head of Research & Development Common Stock 0 $46.99 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Officer Title: EVP, Head of Research & Development Restricted Stock Units 0 Oct 5, 2022 Direct
Global Blood Therapeutics, Inc. Officer Title: EVP, Head of Research & Development Stock Option (Right to Buy) 0 Oct 5, 2022 Direct

Insider Reports Filed by Kim Smith-Whitley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GBT Global Blood Therapeutics, Inc. Oct 5, 2022 7 $0 4 Oct 6, 2022 Officer Title: EVP, Head of Research & Development
GBT Global Blood Therapeutics, Inc. Sep 1, 2022 3 -$41.4K 4 Sep 6, 2022 Officer Title: EVP, Head of Research & Development
GBT Global Blood Therapeutics, Inc. Jun 1, 2022 3 -$39.9K 4 Jun 3, 2022 Officer Title: EVP, Head of Research & Development
GBT Global Blood Therapeutics, Inc. Mar 1, 2022 3 $0 4 Mar 3, 2022 Officer Title: EVP, Head of Research & Development
GBT Global Blood Therapeutics, Inc. Jun 1, 2021 1 $0 4/A Jun 21, 2021 Officer
GBT Global Blood Therapeutics, Inc. May 3, 2021 0 $0 3 May 7, 2021 EVP, Head of Research & Development EXHIBIT 24: POWER OF ATTORNEY